By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


7TM Pharma 

3 Fremtidsvej

Hoersholm    DK-2970  Denmark
Phone: 45-314-525 05 Fax: n/a




Company News
7TM Pharma Successfully Conducts Clinical Phase I Trial of Its First in Class Peripheral CB1 Receptor Antagonist TM38837 Demonstrating Restriction from the Human CNS 11/11/2010 12:36:11 PM
7TM Pharma Completes Positron Emission Tomography Preclinical Research Program To Successfully Demonstrate Peripheral Restriction Of Its CB1 Receptor Antagonist TM38837 7/12/2010 1:59:53 PM
7TM Pharma: A Potential New Treatment For Cancer Supportive Care And Gastrointestinal Diseases 4/23/2010 1:54:45 PM
7TM Pharma Successfully Conducts Clinical Phase I Trial With Its Second Generation CB1 Receptor Antagonist 2/4/2010 3:13:00 PM
7TM Pharma Closes A Financing Round And Sells Certain Early Stage Discovery Assets And Technology To OSI Pharmaceuticals, Inc. (OSIP) 1/15/2009 11:50:26 AM
7TM Pharma Has Initiated Phase I/IIa Clinical Trial with TM30339 9/2/2008 11:45:41 AM
7TM Pharma Receives Milestone Payment from Asthma and Allergy Collaboration 4/16/2008 1:57:08 PM
Dr. Reddy's Laboratories Ltd. (RDY)'s Enters Into Drug Discovery Collaboration With 7TM Pharma on Selected Drug Targets 3/10/2008 7:00:41 AM
7TM Pharma Positive Results from Two Clinical Phase I Studies with the Drug Candidate TM30339 for the Treatment of Obesity 2/27/2008 8:46:57 AM
7TM Pharma Announces Selection of a New Pre-clinical Development Candidate 2/6/2008 7:04:09 AM